Overview

The Effects of Empagliflozin on Renal Outcomes in Post Severe Acute Kidney Injury Survivors

Status:
Not yet recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
Effects of Empagliflozin compared with placebo in post severe acute kidney injury survivors, evaluated by MAKE365.
Phase:
Phase 1
Details
Lead Sponsor:
Chulalongkorn University
Treatments:
Empagliflozin